Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease.
Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG. · 2015
Read Soluble amyloid-β oligomers as synaptotoxins leading to cognitive impairment in Alzheimer's disease. by Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4443025.txt.
Introduction
Sergio Ferreira, Mychael Lourenco, Mauricio Oliveira, and Fernanda De Felice reviewed amyloid-beta oligomers in Alzheimer's disease in Frontiers in Cellular Neuroscience in 2015. Alzheimer's is the most common dementia in older people, and cases keep rising worldwide. The amyloid-beta peptide, which clumps into the plaques found in patients' brains, has long been a prime suspect in memory loss.
Evidence gathered over about fifteen years points to a smaller, dissolved form: clusters called oligomers that float free rather than sit in plaques. These clusters attack synapses, the junctions where brain cells pass signals, and so may drive early mental decline. Many basic questions remain open, including the clusters' exact makeup, which cell receptors they bind, and which signals they trigger. The review sums up progress on each and the treatment ideas that follow from it.
Catalog record
| CREATOR | Ferreira ST, Lourenco MV, Oliveira MM, De Felice FG. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 112 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |